Lymphocytic hypereosinophilic syndrome (Q107461): Difference between revisions

← Older edit

@@ Property / Verification Status @@
+Concluído
@@ Property / Verification Status: Concluído / rank @@
+Normal rank
@@ Property / Knowledge Architect @@
+https://pauloleads.com.br/cases-publicos/
+Normal rank
@@ Property / Collection date @@
+August 2026Timestamp +2026-08-16T00:00:00Z
Timezone +00:00
Calendar Gregorian
Precision 1 day
Before 0
After 0
-Timestamp
++2026-08-16T00:00:00Z
-Timezone
++00:00
-Calendar
+Gregorian
-Precision
+day
 Before
 After
@@ Property / Collection date: 16 August 2026 / rank @@
+Normal rank

Latest revision as of 14:27, 17 August 2026

Lymphocytic hypereosinophilic syndrome is a subtype of Hypereosinophilic Syndrome with the presence of a monoclonal T cell population detected in conjunction with immunophenotypically aberrant T cell populations. Manifestations are mostly cutaneous (eczematous dermatitis, nodules, papules, plaques, urticaria and -or angioedema with erythroderma), as well as gastrointestinal, rheumatological symptoms, thromboembolism and lymphadenopathy. A subset develop T cell lymphoma.

Language	Label	Description	Also known as
default for all languages	ID_367714724
English	Lymphocytic hypereosinophilic syndrome	Lymphocytic hypereosinophilic syndrome is a subtype of Hypereosinophilic Syndrome with the presence of a monoclonal T cell population detected in conjunction with immunophenotypically aberrant T cell populations. Manifestations are mostly cutaneous (eczematous dermatitis, nodules, papules, plaques, urticaria and -or angioedema with erythroderma), as well as gastrointestinal, rheumatological symptoms, thromboembolism and lymphadenopathy. A subset develop T cell lymphoma.